GROOM JOHN 4
4 · LIGAND PHARMACEUTICALS INC · Filed May 17, 2005
Insider Transaction Report
Form 4
GROOM JOHN
Director
Transactions
- Exercise/Conversion
Common Stock
2005-05-17$5.81/sh+16,237$94,378→ 16,237 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-05-17−16,237→ 0 totalExercise: $5.81From: 1996-05-17Exp: 2005-05-17→ Common Stock (16,237 underlying)
Footnotes (1)
- [F1]The transaction is the exercise of a derivative security. No price applies.